{"page_content": "ESG Report 2023\nCorporate Headquarters\nAgios Pharmaceuticals, Inc.\n88 Sidney StreetCambridge, MA 02139-4169\nwww.agios.com\n     NinaMaria,  \nliving with thalassemia ", "metadata": {"source": "NASDAQ_AGIO_2022.pdf", "page": 45, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}